New ICON Biotech survey reveals: China now conducts 25% of global clinical trials. Neurology & cardiology overtaking oncology in R&D focus. Plus insights on funding, AI, and talent. Read the full Q&A. #Biotech #ClinicalTrials #PharmaInnovation #AI

How can AI improve healthcare? By listening. Sciensus uses ambient AI to capture patient insights & give nurses more time for human care. Transforming the patient experience. #FutureOfHealthcare #AIforGood #NurseTech #Microsoft #PatientCentric

The CAR T field is shifting to in vivo platforms that aim to make powerful cell therapies simpler, cheaper, and more accessible. Insights from Vyriad's Luke Russell. #CARTcell #immunotherapy #invivo #biotech #Vyriad #oncology #celltherpay

Cost shouldn’t be your first question in pharma supply chains, says Vector Labs’ Kum Ming Woo. Prioritize quality & availability, diversify geographically, and adopt stage-appropriate strategies. #Interview #Expert #Pharma #SupplyChain #Biotech #Resilience #DrugDevelopment

New study from Rapid Nexus challenges old view of nerve damage. Research shows targeting neuropathy can heal tissue once considered unsalvageable, helping patients avoid amputation. #News #Diabetes #WoundCare #Neuropathy #MedicalInnovation #Research

In 2026, hospitals will split between running their own local AI and forming trusted partnerships, while certified AI medical devices gain major trust, says myTomorrow's Danny den Hamer. #AIinHealthcare #HealthTech2026 #SaMD #LLM #DigitalHealth #Tends

Arkin Capital launches $100M Arkin Bio Ventures III to back transformative biotech companies. The fund takes a hands-on, science-driven approach as an active partner from day one. #News #Interview #Biotech #VentureCapital #Therapeutics #DrugDiscovery

ten23 health & BD partner to enable supply chain readiness for the BD Libertas wearable injector. The full-service solution aims to speed development of large-volume, self-administered therapies. #News #SupplyChain #WearableInjector #Biotech #Pharma #DrugDelivery #Partnership

Genesipre’s gene therapy GENE202 has received Orphan Drug Designation for methylmalonic acidemia (MMA), a rare pediatric disease. #News #GeneTherapy #RareDisease #OrphanDrug #MMA #Biotech

Brainomix's AI imaging tech will serve as a co-primary endpoint in Boehringer Ingelheim's Phase 3 DROP-FPF trial for pulmonary fibrosis—a first for ILD studies. #AI #News #ClinicalTrials #PulmonaryFibrosis #MedicalImaging #Brainomix

VCU researchers awarded $1.8M DoD grant to develop a novel engineered NK cell therapy targeting incurable, advanced prostate cancer (CRPC). #News #ProstateCancer #Immunotherapy #CRPC #CellTherapy #NKcells #IL24 #DoDgrant

Abbott’s $21B acquisition of Exact Sciences signals a new era in cancer detection. We analyze the high-stakes MCED market, pivotal FDA decisions, and the reimbursement battle ahead with Gabelli Funds’ Elena Meng. #MCED #cancerscreening #Abbott #ExactSciences #healthcareinvesting #biotech

FDA approves Stereotaxis MAGiC robotic ablation catheter. A breakthrough for treating complex heart arrhythmias with precise magnetic navigation. #News #Stereotaxis #FDAapproval #cardiology #robotics #arrhythmia #healthtech

Clinical trial start-up delays are rising due to complex protocols & contract bottlenecks. ICON survey data reveals 55% of sites take 5+ months to activate. Solutions require site-centricity & smarter tech. #Interview #ClinicalTrials #StudyStartup #SiteCentricity #ICON #DrugDevelopment

EA Pharma (Eisai) starts Phase III trial in Japan for evenamide, a novel glutamate modulator for schizophrenia. The drug was licensed as part of a €117M deal with Newron Pharmaceuticals. #News #Schizophrenia #ClinicalTrial #MentalHealth #Biotech #Eisai #Evenamide

Canopy secures $22M Series B to expand its connected safety platform for combating workplace violence and modernize hospital operations with location intelligence. #News #HealthTech #SeriesB #WorkplaceSafety #Innovation #LocationIntelligence

New #research by endogene.bio reveals why #endometriosis treatments often fail. The study identifies molecular subgroups & predicts drug response, suggesting non-invasive monitoring via menstrual blood could guide precision therapy. #News #WomensHealth #PrecisionMedicine #ClinicalTrials

Gallop’s LYT-200 shows 13.2-month median survival in late-line AML at #ASH2025—far exceeding historic benchmarks. The anti-galectin-9 antibody combines strong efficacy with a clean safety profile. #News #Leukemia #Oncology #Biotech #ClinicalTrials #AML

Healing chronic wounds twice as fast? SweetBio’s honey-based biomaterial is tackling the hidden amputation crisis, blending ancient remedies with cutting-edge science. #News #WoundCare #Diabetes #MedTech #Innovation #Biomaterials #DiabeticFootUlcer

CNS Pharmaceuticals re-engineers old chemotherapies to cross the blood-brain barrier, targeting aggressive glioblastoma. Dr. Sandra Silberman explains their "back to the future" strategy and two promising drugs. #BrainCancer #Glioblastoma #Biotech #Oncology #BloodBrainBarrier #CNSPharmaceuticals

New data at #ASH2025 show Secure Bio's Copiktra's (duvelisib) consistent efficacy in heavily pretreated PTCL, with strong signal in AITL informing Phase 3 TERZO trial in nTFHL. #news #interview #lymphoma #clinicaltrials #oncology

FoRx Therapeutics raises $50M Series A to advance clinical trial of FORX-428, a PARG inhibitor for PARP-resistant cancers. Initial data expected mid-2026. #News #Biotech #Funding #Oncology #ClinicalTrials #PARG

CTMC’s global alliance partners with Brazil’s Einstein Hospital to democratize cell therapy. CTMC’s Amy Hay details a partnership model to share knowledge and expand cell therapy access worldwide. #News #Interview #CellTherapy #GlobalHealth #MedicalInnovation

FDA approves Cardamyst, the Milestone Pharmaceuticals’ self-administered nasal spray for PSVT. A rapid at-home treatment for sudden rapid heart episodes, available in 2026. #News #PSVT #CARDAMYST #FDAapproval #HeartHealth #MedicalNews

Dr. Margaret Kalmeta, CEO of Rapid Nexus, discusses the first device cleared to treat the tissue around chronic wounds, aiming to prevent amputations. Read more for company's pipeline and future plans #MedTech #WoundCare #FDA #Diabetes #Innovation #Interview #News

New data from Agendia's FLEX study at #SABCS2025 shows genomic signatures like MammaPrint can guide chemo choices & identify benefit in elderly patients. #news #breastcancer #precisionmedicine #realworldevidence

HeartBeam receives FDA clearance for the first cable-free, at-home 12-lead ECG. This breakthrough allows for clinical-grade heart rhythm assessment anytime, anywhere. A major leap for remote cardiac care. #New #HeartBeam #FDA #MedTech #Cardiology #DigitalHealth

AC Immune's Phase 2 vaccine for Parkinson’s shows first-ever signs of potentially slowing disease progression. 100% 100% responder rate for immunogenicity & stabilized biomarkers signal a promising step forward. #News #Parkinsons #Biotech #ClinicalTrial #Neurodegenerative #ACI7104

VUGENE teams up with CRO Inotiv to accelerate AI-driven drug discovery through advanced multi-omics analysis. A key move into the pharmaceutical services market. #News #AI #DrugDiscovery #MultiOmics #Bioinformatics #CRO #Biotech

Sanofi’s #ASH25 data highlight leadership in rare blood diseases, from multi-immune modulation with #BTKinhibitor Wayrilz to long-term hemophilia care with ALTUVIIIO. Transforming patient lives through science. #News #Interview #RareDisease #Hemophilia #Immunoscience

Vyome shares rise on positive Phase 2 data for its wound care gel VT-1953, showing significant reduction in odor & pain. Pivotal study targeted for 2026. #News #Biotech #ClinicalTrial #Healthcare #WoundCare

Tessera Therapeutics' Gene Writing platform hits new preclinical milestones. Data shows edited stem cells exceed curative thresholds for sickle cell disease & successful in vivo generation of functional CAR-T cells. #News #GeneWriting #SickleCellDisease #CAR_T #ASH2025 #Biotech

BREAKING: Dicot Pharma unveils how LIB-01, a new class of ED drug, works. It targets the brain's melanocortin system for a sustained effect, even in non-responders. Phase 2a data shows benefits last 8+ weeks. #News #EDtreatment #menshealth #clinicaltrial #ErectileDysfunction

New data reveals ATIVA's RECELL spray-on skin treatment reduces burn patient hospital stays by 5.6 days, saving ~$42k per case. The minimally invasive approach means less pain, faster healing, and better cosmetic outcomes. #BurnCare #News #MedicalInnovation #PatientOutcomes #HealthcareEfficiency

Iolyx Therapeutics partners with Laboratoires Théa in a deal worth up to $280M to advance ILYX-002, a novel eye drop for autoimmune dry eye. Phase 2 data showed early, sustained improvement. #news #biotech #ophthalmology #dryeye #autoimmune #collaboration

Shocked by the lack of funding in women's health, BioMed X launches XFem Labs with Gates Foundation to bridge the R&D gap. Their first mission: non-hormonal contraception. #News #WomensHealth #HealthEquity #Biotech #GatesFoundation #Innovation

Pharvaris announces positive Phase 3 results for oral deucrictibant in HAE. The drug showed rapid symptom relief in 1.28 hrs & was well-tolerated. Regulatory filings are planned for H1 2026. #News #Pharvaris #deucrictibant #HAE #RareDisease #Phase3 #Biotech

Brainomix's AI imaging (Brainomix 360) doubled endovascular thrombectomy rates & cut transfer delays by 64 mins across 107 NHS hospitals. #News #Study #Stroke #AI #DigitalHealth #Thrombectomy #NHS

New hope against snakebites! 🐍 COVID-era mRNA tech could create a faster, broader treatment to prevent death & disability. A game-changer for rural communities. #mRNA #Snakebite #GlobalHealth #Biotech #MedicalInnovation

Santersus AG raises Series A funding led by Norcliffe Capital. Also, a new strategic collaboration with Terumo aims to advance NucleoCapture, a breakthrough blood purification device, into pivotal trials for sepsis. #News #Biotech #MedTech #Sepsis #Funding #Innovation #SeriesA

Regeneron Pharmaceuticals and Tessera Therapeutics sign a $275 million deal to develop TSRA-196, a potential one-time #GeneEditing therapy for Alpha-1 Antitrypsin Deficiency. #News #deal #partneship #GeneTherapy #AATD #Pharma

Salignostics launches SaliStick, the world's first saliva pregnancy test, across Australia in partnership with Coles. #News #SaliStick #SalivaTest #HealthTech #WomensHealth #Salignostics

Big news in India! Biocomposites' Stimulan Rapid Cure now has expanded approval to be mixed with more antibiotics & the world's first approval for antifungals, helping surgeons fight surgical infections. 🦠⚔️ #News #STIMULAN #Biocomposites #MedTech #SurgicalInfections #Ortho #India #AMR

Bracco, Limula, and University of Fribourg partner to revolutionize cell therapy manufacturing. Their novel approach uses gentle buoyancy-based tech to improve product quality and patient outcomes. #News #Partnership #CellTherapy #Biotech #Innovation #CAR-T #Manufacturing

RapidAI gains FDA clearance for 5 new clinical AI modules, expanding its platform to advance stroke, neurology, and vascular care. #News #AI #HealthTech #FDA #Radiology #Stroke #Innovation #FDAclearance #AIimaging

NanoTemper's acquisition of Envue & launch of Dianthus α let researchers see single molecules & slow kinetics in real time. Transforming early drug discovery. #News #Interivew #DrugDiscovery #Biotech #Innovation #Therapeutics #Manufacturing

Circio's new circVec 4.0 boosts gene expression by 50%. New data shows stronger heart performance and 4x higher brain expression, opening new CNS therapy avenues. #News #Biotech #GeneTherapy #RNA #CNS #Opthalmology

Levron Medical exits stealth with new CRPA tech aimed at transforming heart failure treatment. Backed by new funding and early clinical results, the company is moving into validation at Sheba Medical Center. #News #MedTech #Innovation #HeartFailure #Healthcare #ClinicalResearch #IsraelTech

Sorcero raised $42.5 million in Series B funding to scale its AI-powered life sciences platform. #News #AI #Pharma #LifeSciences #HealthcareInnovation #Funding #MedTech

Voio emerges from stealth with $8.6M to transform radiology. Its new AI, Pillar-0, is the world's most accurate model for medical imaging, outperforming Google & Microsoft. #News #AI #Radiology #HealthTech #Imaging #opensource